https://sputnikglobe.com/20260731/20-patients-will-receive-russias-personalized-melanoma-vaccine-by-yearend--1124520354.html
20 Patients Will Receive Russia's Personalized Melanoma Vaccine by Year‑End
20 Patients Will Receive Russia's Personalized Melanoma Vaccine by Year‑End
Sputnik International
Twenty patients will receive Russia's first skin cancer vaccine by the end of 2026, Alexander Gintsburg, academician of the Russian Academy of Sciences and scientific director of the Gamaleya National Research Center of Epidemiology and Microbiology, told Sputnik.
2026-07-31T03:16+0000
2026-07-31T03:16+0000
2026-07-31T04:25+0000
russia
russia
russian academy of sciences (ras)
russian health ministry
alexander gintsburg
vaccine
https://cdn1.img.sputnikglobe.com/img/07e8/07/0f/1119378556_0:159:2802:1735_1920x0_80_0_0_643eea7bcda28677383712017fc442cf.jpg
"A total of 20 patients are planned to receive the personalized cancer vaccine by the end of the year," Gintsburg said. In April, the National Medical Research Center of Radiology of the Russian Health Ministry administered a personalized mRNA antitumor vaccine "Neooncovac" to a patient with skin melanoma for the first time in clinical practice. The project was developed in collaboration between the National Medical Research Center of Radiology and the Gamaleya Center.
russia
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2026
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
russia, russian academy of sciences (ras), russian health ministry, alexander gintsburg, vaccine
russia, russian academy of sciences (ras), russian health ministry, alexander gintsburg, vaccine
20 Patients Will Receive Russia's Personalized Melanoma Vaccine by Year‑End
03:16 GMT 31.07.2026 (Updated: 04:25 GMT 31.07.2026) Twenty patients will receive Russia's first skin cancer vaccine by the end of 2026, Alexander Gintsburg, academician of the Russian Academy of Sciences and scientific director of the Gamaleya National Research Center of Epidemiology and Microbiology, told Sputnik.
"A total of 20 patients are planned to receive the personalized cancer vaccine by the end of the year," Gintsburg said.
In April, the National Medical Research Center of Radiology of the Russian Health Ministry administered a personalized mRNA antitumor vaccine "Neooncovac" to a patient with skin melanoma for the first time in clinical practice. The project was developed in collaboration between the National Medical Research Center of Radiology and the Gamaleya Center.
